Medical researchers have gained new insights into the mechanism of vaccine-induced T cell immunity, including regulation, gene expression and metabolic pathways. This study used samples from a Phase 1 clinical trial for TAK-003, a live-attenuated tetravalent dengue vaccine. Though these discoveries occurred in the context of a dengue vaccine trial, they are applicable to the development of vaccines for numerous viral diseases.